Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
29.92
+0.05 (0.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
Immunocore Holdings Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Immunocore Holdings stock have an average target of 65.18, with a low estimate of 24 and a high estimate of 100. The average target predicts an increase of 117.85% from the current stock price of 29.92.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunocore Holdings stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 2 | 2 | 2 | 2 |
| Buy | 7 | 8 | 7 | 6 | 6 | 6 |
| Hold | 1 | 2 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 14 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +234.22% | Jan 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $71 | Strong Buy | Reiterates | $71 | +137.30% | Jan 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $74 → $35 | Buy → Hold | Downgrades | $74 → $35 | +16.98% | Dec 13, 2024 |
| Mizuho | Mizuho | Buy → Hold Downgrades $72 → $38 | Buy → Hold | Downgrades | $72 → $38 | +27.01% | Nov 11, 2024 |
| Needham | Needham | Strong Buy Maintains $78 → $71 | Strong Buy | Maintains | $78 → $71 | +137.30% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
321.48M
from 249.43M
Increased by 28.89%
Revenue Next Year
363.26M
from 321.48M
Increased by 13.00%
EPS This Year
-0.85
from -1.13
EPS Next Year
-1.53
from -0.85
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 419.2M | 479.1M | 526.1M | |||
| Avg | 321.5M | 363.3M | 393.1M | |||
| Low | 298.2M | 318.3M | 343.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 68.0% | 49.0% | 44.8% | |||
| Avg | 28.9% | 13.0% | 8.2% | |||
| Low | 19.6% | -1.0% | -5.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.48 | -0.22 | -0.61 | |||
| Avg | -0.85 | -1.53 | -1.97 | |||
| Low | -1.45 | -2.54 | -3.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.